160 related articles for article (PubMed ID: 33211105)
1. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
2. Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer.
Carbajal-Ochoa W; Bravo-Solarte DC; Bernal AM; Anampa JD
Breast Cancer Res Treat; 2024 Jan; 203(2):257-269. PubMed ID: 37833449
[TBL] [Abstract][Full Text] [Related]
3. Lumpectomy followed by radiation improves survival in HER2 positive and triple-negative breast cancer with high tumor-infiltrating lymphocytes compared to mastectomy alone.
Mouabbi JA; Chand M; Asghar IA; Sakhi R; Ockner D; Dul CL; Hadid T; Aref A; Rimawi MF; Hoyos V
Cancer Med; 2021 Jul; 10(14):4790-4795. PubMed ID: 34080777
[TBL] [Abstract][Full Text] [Related]
4. Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy.
Krug D; Vladimirova V; Untch M; Kühn T; Schneeweiss A; Denkert C; Ataseven B; Solbach C; Gerber B; Tesch H; Golatta M; Seiler S; Heil J; Nekljudova V; Holtschmidt J; Loibl S
Breast; 2024 Apr; 74():103701. PubMed ID: 38422624
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer.
Hatzipanagiotou ME; Pigerl M; Gerken M; Räpple S; Zeltner V; Hetterich M; Ugocsai P; Inwald EC; Klinkhammer-Schalke M; Ortmann O; Seitz S
Breast Cancer Res Treat; 2024 Apr; 204(3):607-615. PubMed ID: 38238552
[TBL] [Abstract][Full Text] [Related]
6. 21-gene recurrence score in predicting the outcome of postoperative radiotherapy in T1-2N1 luminal breast cancer after breast-conserving surgery.
Xie SJ; Wang RJ; Wu SG; Zhang FX
Breast; 2024 Apr; 74():103679. PubMed ID: 38367283
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative radiotherapy versus whole-breast external beam radiotherapy, and other factors associated with the prognosis of early breast cancer treated with breast-conserving surgery and radiotherapy: a retrospective study from SEER database.
Sun MS; Liu HJ; Liu YH; Xu L; Ye JM
Transl Cancer Res; 2020 Nov; 9(11):7125-7139. PubMed ID: 35117317
[TBL] [Abstract][Full Text] [Related]
8. Better survival was found in patients treated with breast-conserving surgery compared with mastectomy in malignant phyllodes tumor of the breast.
Chen CY; Ya-Chen
Updates Surg; 2024 Jan; 76(1):265-270. PubMed ID: 37289397
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Leon-Ferre RA; Jonas SF; Salgado R; Loi S; de Jong V; Carter JM; Nielsen TO; Leung S; Riaz N; Chia S; Jules-Clément G; Curigliano G; Criscitiello C; Cockenpot V; Lambertini M; Suman VJ; Linderholm B; Martens JWM; van Deurzen CHM; Timmermans AM; Shimoi T; Yazaki S; Yoshida M; Kim SB; Lee HJ; Dieci MV; Bataillon G; Vincent-Salomon A; André F; Kok M; Linn SC; Goetz MP; Michiels S;
JAMA; 2024 Apr; 331(13):1135-1144. PubMed ID: 38563834
[TBL] [Abstract][Full Text] [Related]
10. Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients.
Saadatmand S; Bretveld R; Siesling S; Tilanus-Linthorst MM
BMJ; 2015 Oct; 351():h4901. PubMed ID: 26442924
[TBL] [Abstract][Full Text] [Related]
11. Effect of adjuvant radiotherapy on overall survival and breast cancer-specific survival of patients with malignant phyllodes tumor of the breast in different age groups: a retrospective observational study based on SEER.
Yang P; Zhang G; Zhang Y; Zhao W; Tang J; Zeng S; Lv X; Lv L
Radiat Oncol; 2024 May; 19(1):59. PubMed ID: 38773616
[TBL] [Abstract][Full Text] [Related]
12. Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer.
Vo K; Ladbury C; Yoon S; Bazan J; Glaser S; Amini A
Breast Cancer; 2024 May; 31(3):485-495. PubMed ID: 38507145
[TBL] [Abstract][Full Text] [Related]
13. Breast conserving surgery combined with radiation therapy offers improved survival over mastectomy in early-stage breast cancer.
Vasilyeva E; Nichol A; Bakos B; Barton A; Goecke M; Lam E; Martin E; Lohrisch C; McKevitt E
Am J Surg; 2024 May; 231():70-73. PubMed ID: 37246127
[TBL] [Abstract][Full Text] [Related]
14. Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century.
Yadav S; Karam D; Bin Riaz I; Xie H; Durani U; Duma N; Giridhar KV; Hieken TJ; Boughey JC; Mutter RW; Hawse JR; Jimenez RE; Couch FJ; Leon-Ferre RA; Ruddy KJ
Cancer; 2020 Jan; 126(1):26-36. PubMed ID: 31588557
[TBL] [Abstract][Full Text] [Related]
15. Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.
Kurian AW; Lichtensztajn DY; Keegan TH; Nelson DO; Clarke CA; Gomez SL
JAMA; 2014 Sep; 312(9):902-14. PubMed ID: 25182099
[TBL] [Abstract][Full Text] [Related]
16. Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer.
Afghahi A; Purington N; Han SS; Desai M; Pierson E; Mathur MB; Seto T; Thompson CA; Rigdon J; Telli ML; Badve SS; Curtis CN; West RB; Horst K; Gomez SL; Ford JM; Sledge GW; Kurian AW
Clin Cancer Res; 2018 Jun; 24(12):2851-2858. PubMed ID: 29581131
[No Abstract] [Full Text] [Related]
17. Treatment patterns, healthcare resource utilization and outcomes for early stage triple-negative breast cancer in Japan.
Sanno H; Taniguchi K; Yoshimoto Y; Saji S
Future Oncol; 2024 Apr; 20(13):833-849. PubMed ID: 38305038
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported symptoms before adjuvant locoregional radiotherapy for breast cancer: triple-negative histology impacts the symptom burden.
Nieder C; Johnsen SK; Winther AM; Mannsåker B
Strahlenther Onkol; 2024 Jun; 200(6):507-511. PubMed ID: 38530418
[TBL] [Abstract][Full Text] [Related]
19. Predicting the survival benefit of local surgery in patients aged 70 years or older with stage IV breast cancer: A population-based analysis.
Chen YQ; Xu JW; Xu XF; Wang XL; Huo LQ; Wang L; Zhou GH; Gu J
Breast; 2021 Oct; 59():124-134. PubMed ID: 34229127
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of breast reconstruction for N2-3M0 stage female breast cancer on breast cancer-specific survival: A population-based propensity score analysis.
Zhao Y; Yan L; Li S; Yang Z; Chai N; Qiu P; Zhang H; He J; Zhou C
Cancer Med; 2023 Oct; 12(20):20287-20298. PubMed ID: 37795774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
